Exchange Capital Management, Inc. Abb Vie Inc. Transaction History

Exchange Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $199,485 - $219,609	-1,950 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $156,955 - $211,906	1,950 New	1,950 $209,000
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $4,515 - $5,568	-58 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $5,156 - $5,732	58 New	58 $5,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Exchange Capital Management, Inc. with notifications on news.